The Pattern of Weight Gain and Change of Peripheral Serum Lipid Profiles in Idiopathic Epileptic Children Treated with Valproate.
- Author:
In Cheol KIM
1
;
Eung Seok KIM
;
Eun Joo BAE
;
Won Il PARK
;
Hong Gin LEE
;
Kyeung Ja LEE
Author Information
1. Department of Pediatrics, Hallym University, College of Medicine, Chuncheon Korea. kiclws@zaigen.co.kr
- Publication Type:Original Article
- Keywords:
Valproate;
Body mass index;
Arm fat area;
Arm muscle area;
Lipid profiles
- MeSH:
Adipose Tissue;
Arm;
Body Composition;
Body Mass Index;
Child*;
Cholesterol;
Humans;
Lipoproteins, HDL;
Lipoproteins, LDL;
Obesity;
Risk Factors;
Skinfold Thickness;
Valproic Acid*;
Weight Gain*
- From:
Journal of the Korean Child Neurology Society
2002;10(1):81-86
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: This study was performed to investigate the change of weight and body composition, and lipid profiles in the idiopathic epileptic children treated with valproate. METHODS: We measured the weight, height, left arm circumference, left triceps skinfold thickness of 30 idiopathic epileptic children treated with valproate before, at 1 month and 4 months of treatment. We also analyzed the serum lipid profiles of the patients before and at 4 months of treatment. We analyzed the change of Body Mass Index (BMI), Arm Muscle Area(AMA), Arm Fat Area(AFA), and the serum lipid profiles. Two-way analysis of variance, chi-square test and paired-t test were used for statistical analysis. RESULTS: There was no statistically significant change in BMI, AFA, AMA of the patients. But the weight of 13(44.3%) children increased greater than 10% with valproate treatment. AMA were not changed, but AFA were significantly increased, 791.2+/-209.6 mm2 before treatment, 858.1+/-246.6 mm2 at 1 month, 1051.7+/-393.2 mm2 at 4 months, in 13 patients, whose weight gain were greater than 10%(P<0.05). There was no change in cholesterols, low density lipoproteins, high density lipoproteins of the 30 children. CONCLUSION: The increase of the weight in the children treated with valproate resulted from the increase body fat. So the weight gain may be a risk factor of obesity
